Copyright Reports & Markets. All rights reserved.

Global Transforming Growth Factor Beta 2 Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Transforming Growth Factor Beta 2 Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Transforming Growth Factor Beta 2 Market Size Growth Rate by Product
      • 1.4.2 XOMA-089
      • 1.4.3 Trabedersen
      • 1.4.4 ISTH-0047
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Transforming Growth Factor Beta 2 Market Size Growth Rate by End User
      • 1.5.2 Glioblastoma Multiforme
      • 1.5.3 Open-Angle Glaucoma
      • 1.5.4 Liver Fibrosis
      • 1.5.5 Melanoma
      • 1.5.6 Breast Cancer
      • 1.5.7 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Transforming Growth Factor Beta 2 Market Size
      • 2.1.1 Global Transforming Growth Factor Beta 2 Revenue 2014-2025
      • 2.1.2 Global Transforming Growth Factor Beta 2 Sales 2014-2025
    • 2.2 Transforming Growth Factor Beta 2 Growth Rate by Regions
      • 2.2.1 Global Transforming Growth Factor Beta 2 Sales by Regions
      • 2.2.2 Global Transforming Growth Factor Beta 2 Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Transforming Growth Factor Beta 2 Sales by Manufacturers
      • 3.1.1 Transforming Growth Factor Beta 2 Sales by Manufacturers
      • 3.1.2 Transforming Growth Factor Beta 2 Sales Market Share by Manufacturers
      • 3.1.3 Global Transforming Growth Factor Beta 2 Market Concentration Ratio (CR5 and HHI)
    • 3.2 Transforming Growth Factor Beta 2 Revenue by Manufacturers
      • 3.2.1 Transforming Growth Factor Beta 2 Revenue by Manufacturers (2014-2019)
      • 3.2.2 Transforming Growth Factor Beta 2 Revenue Share by Manufacturers (2014-2019)
    • 3.3 Transforming Growth Factor Beta 2 Price by Manufacturers
    • 3.4 Transforming Growth Factor Beta 2 Manufacturing Base Distribution, Product Types
      • 3.4.1 Transforming Growth Factor Beta 2 Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Transforming Growth Factor Beta 2 Product Type
      • 3.4.3 Date of International Manufacturers Enter into Transforming Growth Factor Beta 2 Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Transforming Growth Factor Beta 2 Sales by Product
    • 4.2 Global Transforming Growth Factor Beta 2 Revenue by Product
    • 4.3 Transforming Growth Factor Beta 2 Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Transforming Growth Factor Beta 2 Breakdown Data by End User

    6 North America

    • 6.1 North America Transforming Growth Factor Beta 2 by Countries
      • 6.1.1 North America Transforming Growth Factor Beta 2 Sales by Countries
      • 6.1.2 North America Transforming Growth Factor Beta 2 Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Transforming Growth Factor Beta 2 by Product
    • 6.3 North America Transforming Growth Factor Beta 2 by End User

    7 Europe

    • 7.1 Europe Transforming Growth Factor Beta 2 by Countries
      • 7.1.1 Europe Transforming Growth Factor Beta 2 Sales by Countries
      • 7.1.2 Europe Transforming Growth Factor Beta 2 Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Transforming Growth Factor Beta 2 by Product
    • 7.3 Europe Transforming Growth Factor Beta 2 by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Transforming Growth Factor Beta 2 by Countries
      • 8.1.1 Asia Pacific Transforming Growth Factor Beta 2 Sales by Countries
      • 8.1.2 Asia Pacific Transforming Growth Factor Beta 2 Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Transforming Growth Factor Beta 2 by Product
    • 8.3 Asia Pacific Transforming Growth Factor Beta 2 by End User

    9 Central & South America

    • 9.1 Central & South America Transforming Growth Factor Beta 2 by Countries
      • 9.1.1 Central & South America Transforming Growth Factor Beta 2 Sales by Countries
      • 9.1.2 Central & South America Transforming Growth Factor Beta 2 Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Transforming Growth Factor Beta 2 by Product
    • 9.3 Central & South America Transforming Growth Factor Beta 2 by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Transforming Growth Factor Beta 2 by Countries
      • 10.1.1 Middle East and Africa Transforming Growth Factor Beta 2 Sales by Countries
      • 10.1.2 Middle East and Africa Transforming Growth Factor Beta 2 Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Transforming Growth Factor Beta 2 by Product
    • 10.3 Middle East and Africa Transforming Growth Factor Beta 2 by End User

    11 Company Profiles

    • 11.1 Autotelic Inc
      • 11.1.1 Autotelic Inc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Autotelic Inc Transforming Growth Factor Beta 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Autotelic Inc Transforming Growth Factor Beta 2 Products Offered
      • 11.1.5 Autotelic Inc Recent Development
    • 11.2 Genzyme Corp
      • 11.2.1 Genzyme Corp Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Genzyme Corp Transforming Growth Factor Beta 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Genzyme Corp Transforming Growth Factor Beta 2 Products Offered
      • 11.2.5 Genzyme Corp Recent Development
    • 11.3 Isarna Therapeutics GmbH
      • 11.3.1 Isarna Therapeutics GmbH Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Isarna Therapeutics GmbH Transforming Growth Factor Beta 2 Products Offered
      • 11.3.5 Isarna Therapeutics GmbH Recent Development
    • 11.4 Novartis AG
      • 11.4.1 Novartis AG Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Novartis AG Transforming Growth Factor Beta 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Novartis AG Transforming Growth Factor Beta 2 Products Offered
      • 11.4.5 Novartis AG Recent Development

    12 Future Forecast

    • 12.1 Transforming Growth Factor Beta 2 Market Forecast by Regions
      • 12.1.1 Global Transforming Growth Factor Beta 2 Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Transforming Growth Factor Beta 2 Revenue Forecast by Regions 2019-2025
    • 12.2 Transforming Growth Factor Beta 2 Market Forecast by Product
      • 12.2.1 Global Transforming Growth Factor Beta 2 Sales Forecast by Product 2019-2025
      • 12.2.2 Global Transforming Growth Factor Beta 2 Revenue Forecast by Product 2019-2025
    • 12.3 Transforming Growth Factor Beta 2 Market Forecast by End User
    • 12.4 North America Transforming Growth Factor Beta 2 Forecast
    • 12.5 Europe Transforming Growth Factor Beta 2 Forecast
    • 12.6 Asia Pacific Transforming Growth Factor Beta 2 Forecast
    • 12.7 Central & South America Transforming Growth Factor Beta 2 Forecast
    • 12.8 Middle East and Africa Transforming Growth Factor Beta 2 Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Transforming Growth Factor Beta 2 Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Transforming Growth Factor Beta 2 market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Transforming Growth Factor Beta 2 market based on company, product type, end user and key regions.

      This report studies the global market size of Transforming Growth Factor Beta 2 in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Transforming Growth Factor Beta 2 in these regions.
      This research report categorizes the global Transforming Growth Factor Beta 2 market by top players/brands, region, type and end user. This report also studies the global Transforming Growth Factor Beta 2 market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Autotelic Inc
      Genzyme Corp
      Isarna Therapeutics GmbH
      Novartis AG

      Market size by Product
      XOMA-089
      Trabedersen
      ISTH-0047
      Others
      Market size by End User
      Glioblastoma Multiforme
      Open-Angle Glaucoma
      Liver Fibrosis
      Melanoma
      Breast Cancer
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Transforming Growth Factor Beta 2 market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Transforming Growth Factor Beta 2 market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Transforming Growth Factor Beta 2 companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Transforming Growth Factor Beta 2 submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Transforming Growth Factor Beta 2 are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Transforming Growth Factor Beta 2 market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now